EFTA01447188.pdf
📄 Extracted Text (107 words)
As of 4/16/14 11;23 pm PX_LAST
Description Trade Date Quantity Current Price Unit Cost Market Value Current Total Cost Unrealized G/L
SANGAMO BIOSCIENCES 5/28/2013 50,000.00 $ 14.12 $ 8.44 $ 706,000.00 422,214.00 $ 283,786.00
BIOGEN 2/14/2012 2,095.00 $ 290.72 $ 119.55 $ 609,058.40 250,454.95 $ 358,603.45
FOUNDATION MEDICINE 1/13/2014 25,000.00 $ 27.27 $ 27.51 $ 681,625.00 687,663.50 $ (6,038.50)
GILEAD SCIENCES INC Multiple 8,100.00 $ 69.31 $ 79.41 $ 561,402.90 643,204.00 $ (81,801.10)
Total Biotech $ 2,558,086.30 $ 2,003,536.45 $ 554,549.85
ARIAD PHARMACEUTICALS Multiple 16,535.00 $ 6.83 5 17.60 $ 112,934.05 290,997.40 S (178,063.35)
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0101743
CONFIDENTIAL SDNY_GM_00247927
EFTA01447188
ℹ️ Document Details
SHA-256
28be378cb8dc1db9fc8809c73d9d10300640caf6653bdafb71902792981a0b61
Bates Number
EFTA01447188
Dataset
DataSet-10
Document Type
document
Pages
1